Highbridge Capital Management

A global alternative investment management firm offering credit and volatility focused solutions.

Venture Capital Active New York, United States Est. 1992
Visit website ↗
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Highbridge Capital Management, LLC is a global alternative investment management firm founded in 1992 by Glenn Dubin and Henry Swieca. It offers credit and volatility-focused solutions across various liquidity and investment profiles, including hedge funds, drawdown vehicles, and co-investments. The firm manages capital for sophisticated investors such as financial institutions, public and corporate pension funds, sovereign wealth funds, endowments, and family offices. Highbridge was acquired by J.P. Morgan Asset Management, with a majority stake purchased in 2004 and full acquisition completed in 2009, and operates as a subsidiary.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Highbridge Capital Management's primary sector focus for investments?
Highbridge Capital Management primarily focuses on the Health Tech & Life Sciences sector, with two portfolio companies in this area.
Can you name some of Highbridge Capital Management's portfolio companies?
Highbridge Capital Management's portfolio includes BiolineRx, which focuses on oncology therapeutic pharmaceutical candidates, and Gamida Cell, which develops cellular and immune therapies.
What types of funding stages has Highbridge Capital Management participated in recently?
Highbridge Capital Management has participated in Debt Financing and PIPE rounds, with one investment in each stage.
When did Highbridge Capital Management make its most recent investments?
Highbridge Capital Management made investments in May 2024 and November 2024.
What is the typical investment range for Highbridge Capital Management?
Highbridge Capital Management typically invests between $9M and $30M.
Has Highbridge Capital Management had any exits from its portfolio companies?
According to startupim data, Gamida Cell, a portfolio company of Highbridge Capital Management, has been acquired.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)